The 2 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 7.00. The median estimate represents a +566.67% increase from the last price of 1.20.
The current consensus among 2 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.08
Reporting Date Aug 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.